Targeted genome editing in acute lymphoblastic leukemia: a review
Sign Up to like & getrecommendations! Published in 2018 at "BMC Biotechnology"
DOI: 10.1186/s12896-018-0455-9
Abstract: BackgroundGenome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies.ResultsWe show how the recent availability of genome-editing tools such as CRISPR-Cas9… read more here.
Keywords: editing acute; genome editing; lymphoblastic leukemia; targeted genome ... See more keywords